The impact of antidepressant treatment on population health: Synthesis of data from two national data sources in Canada

Population Health Metrics

Volumn 2, Issue , 2004, Pages

  Patten, Scott B ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ARTICLE; CALCULATION; CANADA; CONTROLLED STUDY; DATA ANALYSIS; DISEASE DURATION; DISEASE SEVERITY; HEALTH SURVEY; HUMAN; INCIDENCE; INTERVIEW; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MOOD DISORDER; POPULATION RESEARCH; PREDICTION; PREVALENCE; RECURRENT DISEASE; TREATMENT OUTCOME;

EID: 18144406937     PISSN: 14787954     EISSN: None     Source Type: Journal    
DOI: 10.1186/1478-7954-2-9     Document Type: Article

References (15)

1. Reesal RT, Lam RW, Group CANMATDW: Clincical guidelines for the treatment of depressive disorders. II. Principles of management. Can J Psychiatry 2001, 46(Suppl. 1):21S-28S.
2. Neutel CI: A new, "user-friendly" terminology for confounding by indication in the study of adverse drug reactions. Post Marketing Surveillance 1993, 7:363-369.
3. Kessler RC, Andrews G, Mroczek D, Ustun B, Wittchen HU: The World Health Organization Composite International Diagnostic Interview Short-Form (CIDI-SF). Int J Methods Psychiatr Res 1998, 7:171-185.
4. Association AP: Diagnostic and statistical manual of mental disorders. Fourth Edition, text revision Washington, D.C., American Psychiatric Association; 2000.
5. Patten SB, Brandon-Christie J, Devji J, Sedmak B: Performance of the Composite International Diagnostic Interview Short Form for Major Depression in a Community Sample. Chronic Dis Can 2000, 21:68-72.
6. Patten SB, Beck CA: Major depression and mental health care utilization in Canada: 1994-2000. Can J Psychiatry 2004, 49:303-309.
7. Blazer DG, Kessler RC, McGonagle KA, Swartz MS: The prevalence and distribution of Major Depression in a national community sample: the National Comorbidity Survey. Am J Psychiatry 1994, 151:979-986.
8. De Marco RR: The epidemiology of major depression: implications of occurrence, recurrence, and stress in a Canadian community sample. Can J Psychiatry 2000, 45:67-74.
9. Moldin SO, Scheftner WA, Rice JP, Nelson E, Knesevich MA, Akiskal H: Association between major depressive disorder and physical illness. Psychol Med 1993, 23:755-761.
10. Patten SB: Long-term medical conditions and major depression in a Canadian population survey at waves 1 and 2. J Affect Disord 2001, 63:35-41.
11. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994, 51: 8-19.
12. Fava GA: Can long-term treatment with antidepressant drugs worsen the clinical course of depression? J Clin Psychiatry 2003, 64:123-133.
13. Baldessarini RJ, Ghaemi SN, Viguera AC: Tolerance in antidepressant treatment. Psychother Psychosom 2002, 71: 177-179.
14. Patten SB: Psychosocial stress, depressive symptoms and depressive disorders, an integrative hypothesis. Med Hypotheses 1999, 53:210-216.
15. Young AS, Klap R, Sherbourne CD, Wells KB: The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry 2001, 58:55-61.